Diuretics and Digitalis

  • D. Bradley
  • S. Dyke
  • Robert J. Cody


Digitalis plays an important role in the treatment of patients in whom systolic dysfunction is a major component. Although its therapeutic benefits were demonstrated more than two centuries ago, the efficacy of digitalis in the treatment of patients in normal sinus rhythm with heart failure has remained controversial. Further, beneficial effects beyond a direct inotropic or hemodynamic benefit may account for much of the clinical outcome in humans. The absence of a significant reduction in mortality in a large prospective trial (Digitalis Investigation Group [DIG] trial) is balanced against the clinical benefit demonstrated in two independent digoxin withdrawal studies.


Heart Failure Heart Failure Patient Pulmonary Capillary Wedge Pressure Loop Diuretic Diuretic Therapy 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kelly RA, Smith TW: Treatment of stable heart failure: digitalis and diuretics. In Atlas of Heart Diseases, vol IV. Heart Failure: Cardiac Function and Dysfunction. Edited by Colucci WS, Braunwald E. Philadelphia: Current Medicine; 1995:10. 1–10. 16.Google Scholar
  2. 2.
    Wilcox CS, Mitch WE, Kelly RA, et al.: Response to furosemide: I. Effect of salt intake and renal compensation. J Lab Clin Med 1983, 102: 450–458.PubMedGoogle Scholar
  3. 3.
    Sica DA, Deedwania P: Pharmacotherapy in congestive heart failure: principles of combination diuretic therapy in congestive heart failure. Congestive Heart Failure 1997, 3: 29–38.Google Scholar
  4. 4.
    Vargo D, Kramer WG, Black PK, et al.: The pharmacodynamics of torsemide in patients with congestive heart failure. Clin Pharmacol Ther 1994, 56:48–54.PubMedCrossRefGoogle Scholar
  5. 5.
    Rudy DW, Gehr TWB, Matzke G, et al.: The pharmacodynamics of intravenous and oral torsemide in patients with chronic renal insufficiency. Clin Pharmacol Ther 1994, 56:39–47.PubMedCrossRefGoogle Scholar
  6. 6.
    Brater DC: Diuretic therapy. N Engl J Med 1998, 339: 387–395.PubMedCrossRefGoogle Scholar
  7. 7.
    Cody RJ, Pickworth KK: Approaches to diuretic therapy and electrolyte imbalance in congestive heart failure. In Update in Congestive Heart Failure: Cardiology Clinics, vol 12. Edited by Deedwania PC. Philadelphia: WB Saunders; 1994: 37–50.Google Scholar
  8. 8.
    Mason DT, Braunwald E, Karsh RB, et al.:Studies on Digitalis: X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients in heart failure. J Clin Invest 1964, 43:532–543.PubMedCrossRefGoogle Scholar
  9. 9.
    Ferguson DW, Berg WJ, Sanders JS, et al.: Sympathoinhibitory responses to digitalis glycosides in heart failure patients: direct evidence from sympathetic neural recordings. Circulation 1989, 80:65–77.PubMedCrossRefGoogle Scholar
  10. 10.
    Wang W, Chen J-S, Zucker IH: Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation 1990, 81: 1959–1966.PubMedCrossRefGoogle Scholar
  11. 11.
    Gheorghiade M, St Clair J,St Clair C, et al.: Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cordial 1987, 9:849–857.CrossRefGoogle Scholar
  12. 12.
    Captopril-Digoxin Multicenter Research Group: Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988, 259: 539–544.CrossRefGoogle Scholar
  13. 13.
    Uretsky BF, Young JB, Shahidi FE, et al.: Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cordial 1993, 22:955–962.CrossRefGoogle Scholar
  14. 14.
    Packer M, Gheorghiade M, Young JB, et al.:Withdrawal of digoxin from patients with chronic heart failure treated with angiotensinconverting-enzyme inhibitors. N Engl J Med 1997, 329:1–7.CrossRefGoogle Scholar
  15. 15.
    Digitalis Investigation Group: The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group (DIG) Trial. N Engl J Med 1997, 336: 525–533.CrossRefGoogle Scholar
  16. 16.
    Lader E, Egan D, Hunsberger S, et al.:The effect of digoxin on the quality of life in patients with heart failure. J Card Fail 2003, 9:4–12.PubMedCrossRefGoogle Scholar
  17. 17.
    Rathore SS, Curtis JP, Wang Y, et al.: Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003, 289:871–878.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2005

Authors and Affiliations

  • D. Bradley
  • S. Dyke
  • Robert J. Cody

There are no affiliations available

Personalised recommendations